Ketoconazole in the prevention of experimental candidal vaginitis.
The prophylactic and therapeutic activities of ketoconazole were evaluated in rats inoculated intravaginally with Candida albicans. Daily doses of 2.5 mg/kg initiated 48 h before challenge and continued for 48 h thereafter protected 80% of the rats against infection. A similar result in rats with es...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1984
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185491/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6324671/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.2.281 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|